Fig. 1From: Cutaneous allodynia as predictor for treatment response in chronic migraine: a cohort studyFlowchart study population. *All patients started withdrawal treatment from acute migraine mediation. Half of the patients were additionally treated with botulinum toxin A injections prior to start withdrawal in a randomized blinded fashionBack to article page